Palmoplantar pustulosishttps://en.wikipedia.org/wiki/Pustulosis_palmaris_et_plantaris
Ko te Palmoplantar pustulosis he pustular dermatosis mau tonu (ara, he pustulosis, he psoriasis pustular) kei runga i ngā pēke me ngā kapu anake, e tohuhia ana e ngā pustula intraepidermal kua whakakii ki ngā neutrophil. Ko te whakamahi i ngā retinoid anake, me te whakakotahi i te photochemotherapy, hei whakapai ake i ngā tohu o te Palmoplantar pustulosis.

○ Maimoatanga
He whai hua te acitretin oral mō tēnei momo psoriasis.
#Acitretin
☆ AI Dermatology — Free Service
I te 2022 Stiftung Warentest hua mai i Tiamana, he iti noa iho te pai o nga kaihoko ki a ModelDerm i nga korero mo te waea rongoa utu.
  • I tēnei kiri, ka taea hoki te whakapae i te pompholyx.
  • I te korenga o ngā pustules, ka taea hoki te ki i te hakihaki ringa hei tātaritanga rereke.
References Palmoplantar Psoriasis 28846363 
NIH
Ko te Palmoplantar psoriasis he momo psoriasis e pā ana ki te nuinga o te kiri i ō ringaringa me ō kapu. Ka kitea he kiri matotoru, te maroke, te pupuhi, te huinga rānei o ngā momo e rua.
Palmoplantar psoriasis is a variant of psoriasis that characteristically affects the skin of the palms and soles. It features hyperkeratotic, pustular, or mixed morphologies.
 Tumor Necrosis Factor Inhibitors 29494032 
NIH
Tumor necrosis factor (TNF)-alpha inhibitors, including etanercept (E), infliximab (I), adalimumab (A), certolizumab pegol (C), and golimumab (G), are biologic agents which are FDA-approved to treat ankylosing spondylitis (E, I, A, C, and G), Crohn disease (I, A and C), hidradenitis suppurativa (A), juvenile idiopathic arthritis (A), plaque psoriasis (E, I and A), polyarticular juvenile idiopathic arthritis (E), psoriatic arthritis (E, I, A, C, and G), rheumatoid arthritis (E, I, A, C, and G), ulcerative colitis (I, A and G), and uveitis (A).